Gwen Thompson

Gwen Thompson

Auto-generated profile, based on publicly available information

Gwen Thompson

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2016 in Teaching and Learning in Medicine
Verified
Journal Article
Closed access
GTGwen Thompson
Gwen Thompson
RMRosanne B. McBride
Rosanne B. McBride
CHCharles C. Hosford
Charles C. Hosford
GHGwen Halaas
Gwen Halaas
Theory: Although medical students begin medical school with better mental health than their peers, during medical school students have a higher prevalence of psychological distress. Medical students often do not seek help for mental health concerns. The use of approach coping strategies and social support has been shown in other populations to be related to mental health resiliency. Hypotheses: The rates of depression and burnout in this medical student population are expected to be high, with the majority not seeking help for their psychological distress in accordance with studies of medical students across the nation. Perceptions of stigma are hypothesized to be a potential source of this lack of care-seeking behavior. Approach coping strategies and social support are speculated to have an inverse relationship with the prevalence of depression and burnout in the medical student population. Method: Validated measures of depression and burnout along with items pertaining to diagnosis and treatment of mental health issues, specific coping strategies used during stressful times, and perceptions of social support were used in a cross-sectional study of students at the University of North Dakota School of Medicine and Health Sciences (UND SMHS). Results: The overall survey response rate was 64%. Seventeen percent had moderate to severe depression, and 49% had burnout. Of depressed respondents, 81% were undiagnosed. When asked why depression develops, 23% responded that it was due to an inability to cope. A significantly greater risk of depression was associated with inadequate support from family and friends (p = .002), fellow medical students (p = .01), and the UND SMHS (p = .003). Greater use of approach-oriented coping strategies than avoidant-oriented strategies was associated with significantly decreased risk of burnout (p = .02) and was inversely correlated with depression (rs = −0.27, n = 153, p = .001). Conclusions: This study outlines associations among approach-oriented coping strategies, social support, and resiliency to mental health issues among medical students. This study also supports the existing literature that stigma regarding mental health issues is present in the medical community. Further multi-institutional, longitudinal research to delineate whether interventions that promote approach coping style and utilization of social support lead to decreased rates of mental health issues is necessary. The development of these interventions will need to be a multifaceted approach that includes promotion of care-taking behaviors but also focuses on institutional cultural change in order to empower students to participate in these resiliency strategies.

1 November 2018 in Chest
Verified
Journal Article
Open access
GTGwen Thompson
Gwen Thompson
浩関浩至 関口
浩至 関口
DCDong Chen
Dong Chen
JRJay Ryu
Jay Ryu
A 40-year-old male subject employed as a grocery store manager presented to a pulmonary clinic with a dry cough and progressive dyspnea of 1 year duration. The patient was previously an avid cyclist and first noted his dyspnea when he was unable to bike as far as before. Bilateral interstitial lung infiltrates were recently noted on chest radiography. At the time of presentation, he could no longer cycle due to dyspnea. The patient's medical history was significant for albinism and severe visual impairment. He had no family history of albinism or pulmonary disorders. He had never smoked, drank alcohol only occasionally, and had no significant environmental exposures.

1 August 2017 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
GTGwen Thompson
Gwen Thompson
WSWilliam Sanchez
William Sanchez
DSDouglas A. Simonetto
Douglas A. Simonetto

25 February 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
YPYuan-Ping Pang
Yuan-Ping Pang
MMMarta Casal Moura
Marta Casal Moura
GTGwen E. Thompson
Gwen E. Thompson
AHAmber M. Hummel
Amber M. Hummel
DNDarlene R. Nelson
Darlene R. Nelson
USUlrich Specks
Ulrich Specks
Proteinase 3 (PR3) is a neutrophil serine protease targeted by anti-neutrophil cytoplasmic antibodies (ANCAs) in the autoimmune disease granulomatosis with polyangiitis (GPA) 1–5 . PR3 mutants were developed to investigate how PR3 interacts with the ANCAs and whether the interactions can be intervened by therapeutics. One mutant with a Ser195Ala mutation (iPR3-Val 103 ) recognized as many ANCAs as wild-type PR3 (PR3-Val 103 ) 6–9 , indicating that PR3-Val 103 and iPR3-Val 103 have equivalent ANCA-binding capabilities. A triple mutant of the latter (iHm5-Val 103 ) bound a monoclonal antibody (moANCA518) from a patient with GPA on an epitope remote from the mutation sites. Unexpectedly, the corresponding epitope of iPR3-Val 103 was inaccessible to moANCA518 under the same experimental conditions 10,11 . These observations demonstrate that a latent epitope of PR3 can be activated surprisingly by remote mutations in PR3 11 . Here we report a comparative analysis of simulated B-factors (i.e., measurements of local mobility) of PR3-Val 103 , iPR3-Val 103 , and iHm5-Val 103 , demonstrating that the binding of moANCA518 to iHm5-Val 103 is enabled by an increase in main-chain flexibility in the latent epitope caused by the remote muta-tions in iHm5-Val 103 . This epitope activation—achieved in vitro by remote mutations as we demonstrated or in vivo conceivably by remote protein»protein interactions 12 or remote po-lymorphisms—may be a fundamental feature of antibody-mediated autoimmune diseases. Rigidifying B-cell epitopes on an autoantigen with therapeutics designed using the B-factor analysis disclosed here may lead to effective treatments for these autoimmune diseases by making the autoantigen inaccessible to existing autoantibodies. This analysis may also be used to predict and characterize epitopes and remote mutation effects.